1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Hepatitis Tests Overview

3 Products under Development
3.1 Hepatitis Tests - Pipeline Products by Stage of Development
3.2 Hepatitis Tests - Pipeline Products by Segment
3.3 Hepatitis Tests - Pipeline Products by Territory
3.4 Hepatitis Tests - Pipeline Products by Regulatory Path
3.5 Hepatitis Tests - Pipeline Products by Estimated Approval Date

4 Hepatitis Tests - Pipeline Products under Development by Companies
4.1 Hepatitis Tests Companies - Pipeline Products by Stage of Development
4.2 Hepatitis Tests - Pipeline Products by Stage of Development

5 Hepatitis Tests Companies and Product Overview
5.1 Abbott Diagnostics Company Overview
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.2 Access Bio Inc Company Overview
5.2.1 Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Aldatu Biosciences Inc Company Overview
5.3.1 Aldatu Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Alderon Biosciences Inc Company Overview
5.4.1 Alderon Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 AutoGenomics Inc Company Overview
5.5.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 AXO Science SAS Company Overview
5.6.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
5.7 Beckman Coulter Inc Company Overview
5.7.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Biokit SA Company Overview
5.8.1 Biokit SA Pipeline Products & Ongoing Clinical Trials Overview
5.9 Biomagnetics Diagnostics Corp Company Overview
5.9.1 Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 Bio-Rad Laboratories Inc Company Overview
5.10.1 Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Boditech Med Inc Company Overview
5.11.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Celera Corp Company Overview
5.12.1 Celera Corp Pipeline Products & Ongoing Clinical Trials Overview
5.13 CeMines, Inc. (Inactive) Company Overview
5.13.1 CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.14 Cepheid Inc Company Overview
5.14.1 Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 China Medical Technologies Inc (Inactive) Company Overview
5.15.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.16 Co-Diagnostics Inc Company Overview
5.16.1 Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Corgenix Medical Corp Company Overview
5.17.1 Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.18 CrossLife Technologies Inc Company Overview
5.18.1 CrossLife Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Daan Gene Co Ltd Company Overview
5.19.1 Daan Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.20 Diagnostics for the Real World (Europe) Ltd Company Overview
5.20.1 Diagnostics for the Real World (Europe) Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.21 DiaSorin SpA Company Overview
5.21.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview
5.22 D-Kimia, LLC. Company Overview
5.22.1 D-Kimia, LLC. Pipeline Products & Ongoing Clinical Trials Overview
5.23 DNAE Group Holdings Ltd Company Overview
5.23.1 DNAE Group Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.24 DxDiscovery Inc Company Overview
5.24.1 DxDiscovery Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 Ecoli sro Company Overview
5.25.1 Ecoli sro Pipeline Products & Ongoing Clinical Trials Overview
5.26 Ferrer inCode SL Company Overview
5.26.1 Ferrer inCode SL Pipeline Products & Ongoing Clinical Trials Overview
5.27 Fujirebio Diagnostics Inc Company Overview
5.27.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Genome Diagnostics Pvt Ltd Company Overview
5.28.1 Genome Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 HealthTell Inc Company Overview
5.29.1 HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview
5.30 Hepron Molecular Lab Inc Company Overview
5.30.1 Hepron Molecular Lab Inc Pipeline Products & Ongoing Clinical Trials Overview
5.31 Hologic Inc Company Overview
5.31.1 Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Imperial College London Company Overview
5.32.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.33 LifeAssay Diagnostics (Pty) Ltd Company Overview
5.33.1 LifeAssay Diagnostics (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.34 MedMira Inc Company Overview
5.34.1 MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview
5.35 Medosome Biotec LLC Company Overview
5.35.1 Medosome Biotec LLC Pipeline Products & Ongoing Clinical Trials Overview
5.36 Monogram Biosciences Inc Company Overview
5.36.1 Monogram Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.37 NanoDiagX Company Overview
5.37.1 NanoDiagX Pipeline Products & Ongoing Clinical Trials Overview
5.38 Ortho-Clinical Diagnostics Inc Company Overview
5.38.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.39 Paramedical Srl Company Overview
5.39.1 Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview
5.40 ProteinLogic Ltd Company Overview
5.40.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.41 Qiagen NV Company Overview
5.41.1 Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
5.42 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview
5.42.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview
5.43 Roche Diagnostics International Ltd Company Overview
5.43.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.44 Seegene Inc Company Overview
5.44.1 Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview
5.45 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview
5.45.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.46 Siemens Healthcare Diagnostics Inc Company Overview
5.46.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.47 Siemens Healthineers AG Company Overview
5.47.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
5.48 Stanford University Company Overview
5.48.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
5.49 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview
5.49.1 Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.50 Sysmex Corp Company Overview
5.50.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview
5.51 TBG Diagnostics Ltd Company Overview
5.51.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.52 The University of British Columbia Company Overview
5.52.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
5.53 University Medical Center Hamburg-Eppendorf Company Overview
5.53.1 University Medical Center Hamburg-Eppendorf Pipeline Products & Ongoing Clinical Trials Overview
5.54 University of Michigan Company Overview
5.54.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.55 University of Texas Medical Branch at Galveston Company Overview
5.55.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
5.56 University of Warwick Company Overview
5.56.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview
5.57 Ustar Biotechnologies (Hangzhou) Ltd. Company Overview
5.57.1 Ustar Biotechnologies (Hangzhou) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.58 Xiamen Zeesan Biotech Co.,Ltd Company Overview
5.58.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Hepatitis Tests- Recent Developments
6.1 Nov 18, 2020: Change in use of proceeds from the global offering for expansion of R&D portfolio into hepatitis B clinical cure and NASH
6.2 Oct 23, 2020: Mentice receives order of total SEK 7.1 million from ABBOTT
6.3 Aug 20, 2020: Vir Biotechnology presents data on VIR-2218 from clinical studies for the treatment of hepatitis B at the EASL Digital International Liver Congress
6.4 Jul 08, 2020: GenMark Diagnostics: Entry into a Material Definitive Agreement
6.5 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities
6.6 May 28, 2020: QIAGEN builds on leading position in Precision Medicine with novel solutions in oncology
6.7 May 18, 2020: QIAGEN announces publication of Reasoned Position Statement for proposed acquisition by Thermo Fisher and date for Annual General Meeting
6.8 May 13, 2020: OPKO Health's BioReference Laboratories and Westchester Medical Center Health Network enter into strategic laboratory collaboration to deliver operational and diagnostic services
6.9 Apr 16, 2020: Abbott reports first-quarter 2020 results
6.10 Feb 26, 2020: bioMerieux - 2019 financial results
6.11 Feb 18, 2020: Hologic Expands Costa Rican operations with new financial shared services center
6.12 Feb 13, 2020: LabCorp announces 2019 fourth quarter and full year results and provides 2020 guidance
6.13 Feb 13, 2020: Bio-Rad reports fourth-quarter and full-year 2019 financial results
6.14 Feb 11, 2020: Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer
6.15 Feb 05, 2020: Hologic launches new scalable options for panther system in the United States and Europe
6.16 Feb 04, 2020: Bio-Rad brings FCS express flow cytometry analysis software to ZE5 cell analyzer users
6.17 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth - outlook confirmed
6.18 Jan 30, 2020: Quotient provides an update on recent MosaiQ milestone achievements together with third quarter fiscal 2020 results
6.19 Jan 22, 2020: Abbott reports fourth-quarter 2019 results; announces strong forecast for 2020
6.20 Jan 13, 2020: GenMark Diagnostics provides preliminary operational and financial results for 2019
6.21 Jan 13, 2020: Enzo Biochem responds to series of misleading and inaccurate statements from activist hedge fund harbert
6.22 Jan 12, 2020: Hologic announces preliminary financial results for first quarter of fiscal 2020
6.23 Jan 08, 2020: ABBOTT LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
6.24 Jan 07, 2020: Quotient announces appointment of new chief financial officer Peter Buhler and chief operating officer Ed Farrell
6.25 Jan 06, 2020: Bio-Rad appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President
6.26 Dec 31, 2019: Enzo Biochem appoints Rebecca J. Fischer to Board of Directors
6.27 Dec 24, 2019: Ad-hoc announcement pursuant to article 17 market abuse regulation
6.28 Dec 23, 2019: The International Trade Commission issues final decision affirming 10X Genomics infringement of three of Bio-Rad's Patents
6.29 Dec 13, 2019: Bio-Rad makes progress recovering from recent ransomware attack
6.30 Dec 10, 2019: Enzo Biochem reports fiscal first quarter results
6.31 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses

7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Hepatitis Tests - Pipeline Products by Stage of Development
Table 2: Hepatitis Tests - Pipeline Products by Segment
Table 3: Hepatitis Tests - Pipeline Products by Territory
Table 4: Hepatitis Tests - Pipeline Products by Regulatory Path
Table 5: Hepatitis Tests - Pipeline Products by Estimated Approval Date
Table 6: Hepatitis Tests Companies - Pipeline Products by Stage of Development
Table 7: Hepatitis Tests - Pipeline Products by Stage of Development
Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Alinity i Assay - HCV Ag - Product Status
Table 10: Alinity i Assay - HCV Ag - Product Description
Table 11: ARCHITECT c16000 System - HbSAg Assay - Product Status
Table 12: ARCHITECT c16000 System - HbSAg Assay - Product Description
Table 13: ARCHITECT c4000 System - HbSAg Assay - Product Status
Table 14: ARCHITECT c4000 System - HbSAg Assay - Product Description
Table 15: ARCHITECT c8000 System - HbSAg Next Qual Assay - Product Status
Table 16: ARCHITECT c8000 System - HbSAg Next Qual Assay - Product Description
Table 17: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: RDT - HCV Infection - Product Status
Table 19: RDT - HCV Infection - Product Description
Table 20: Aldatu Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: PANDAA Assay - HCV - Product Status
Table 22: PANDAA Assay - HCV - Product Description
Table 23: Alderon Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: eSystem - Qualitative HCV RNA Assay - Product Status
Table 25: eSystem - Qualitative HCV RNA Assay - Product Description
Table 26: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: INFINITI High Throughput System - Hepatitis C Virus (HCV) Genotyping Test - Product Status
Table 28: INFINITI High Throughput System - Hepatitis C Virus (HCV) Genotyping Test - Product Description
Table 29: INFINITI Plus - Hepatitis C Virus (HCV) Genotyping Test - Product Status
Table 30: INFINITI Plus - Hepatitis C Virus (HCV) Genotyping Test - Product Description
Table 31: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Multiplexed Detection - Anti-HCV Antibodies - Product Status
Table 33: Multiplexed Detection - Anti-HCV Antibodies - Product Description
Table 34: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: UniCel DxN - HCV Viral Load Test - Product Status
Table 36: UniCel DxN - HCV Viral Load Test - Product Description
Table 37: Biokit SA Pipeline Products & Ongoing Clinical Trials Overview
Table 38: BIO-FLASH anti-HBe Assay - Product Status
Table 39: BIO-FLASH anti-HBe Assay - Product Description
Table 40: BIO-FLASH HAV Assay - Product Status
Table 41: BIO-FLASH HAV Assay - Product Description
Table 42: BIO-FLASH HBe Ag Assay - Product Status
Table 43: BIO-FLASH HBe Ag Assay - Product Description
Table 44: Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Diagnostic Test - Hepatitis B - Product Status
Table 46: Diagnostic Test - Hepatitis B - Product Description
Table 47: Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 48: BioPlex 2200 - Hepatitis Test - Product Status
Table 49: BioPlex 2200 - Hepatitis Test - Product Description
Table 50: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Hepatitis Tests - Pipeline Products by Stage of Development
Figure 2: Hepatitis Tests - Pipeline Products by Segment
Figure 3: Hepatitis Tests - Pipeline Products by Territory
Figure 4: Hepatitis Tests - Pipeline Products by Regulatory Path
Figure 5: Hepatitis Tests - Pipeline Products by Estimated Approval Date